Japan's Takeda in regulatory talks to launch dengue vaccine in India
The Japanese drugmaker plans to scale up the production of its dengue vaccine Qdenga through a partnership with Indian vaccine maker Biological E., the companies said earlier in the day.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Dengue Fever | India Health | Japan Health | Partnerships | Pharmaceuticals | Vaccines